Choavaratana Roungsin, Manoch Darapa
Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
J Med Assoc Thai. 2004 May;87(5):455-8.
The aim of the study was to compare the efficacy of oral micronized progesterone when applied by the vaginal route. The comparative study of serum progesterone levels between oral and vaginal micronized progesterone administration was conducted in sixty female volunteers. The subjects were equally divided into two groups to receive the drug either via the oral or vaginal route. The subjects' profiles showed that there was no significant difference in general characteristics between these two groups. The blood tests for estrogen and progesterone levels were performed on all volunteers before and after the drug administration. The data collected from the experiment revealed that the serum progesterone levels achieved by oral administration (5.06 +/- 2.95 ng/ml) differed significantly (p < 0.001) from those achieved by vaginal administration (8.26 +/- 4.09 ng/ml). The data also revealed that the serum progesterone levels of the oral administration group (4.23 +/- 2.68 ng/ml) did not differ significantly (p = 0.925) from the other group (4.15 +/- 3.40 ng/ml) when the serum estrogen level was less than 30 pg/ml. On the contrary, when the serum estrogen level was at least 30 pg/ml, there was a significant (p < 0.005) difference in the serum progesterone levels between these two groups (6.32 +/- 2.99 ng/ml for the oral route and 9.76 +/- 3.23 ng/ml for the vaginal route).
该研究的目的是比较经阴道途径应用口服微粒化孕酮的疗效。在60名女性志愿者中进行了口服和阴道给予微粒化孕酮后血清孕酮水平的比较研究。受试者被平均分为两组,分别通过口服或阴道途径接受药物。受试者的资料显示,这两组在一般特征上没有显著差异。在给药前后对所有志愿者进行雌激素和孕酮水平的血液检测。从实验收集的数据显示,口服给药达到的血清孕酮水平(5.06±2.95 ng/ml)与阴道给药达到的水平(8.26±4.09 ng/ml)有显著差异(p<0.001)。数据还显示,当血清雌激素水平低于30 pg/ml时,口服给药组的血清孕酮水平(4.23±2.68 ng/ml)与另一组(4.15±3.40 ng/ml)没有显著差异(p = 0.925)。相反,当血清雌激素水平至少为30 pg/ml时,两组之间的血清孕酮水平有显著差异(p<0.005)(口服途径为6.32±2.99 ng/ml,阴道途径为9.76±3.23 ng/ml)。